CPT code 88350 defines a single-antibody immunofluorescent staining procedure used by pathology laboratories to detect autoimmune disease markers or infectious organisms in tissue or cellular specimens. As a focused laboratory pathology service, it is a critical diagnostic tool for confirming immune-mediated processes and certain infections, influencing downstream clinical management and specialist referral.

This analysis covers national payer practices including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and service delivery settings, common modifiers and billing considerations provided as reference, and what typical coverage patterns and coding relationships are pertinent for lab and pathology services. The report summarizes benchmarks where available, highlights coding interactions relevant to follow-up or sequential staining procedures, and outlines areas where policy updates or payer-specific rules commonly affect claims processing.

The content is intended for billing professionals, laboratory directors, and health policy analysts seeking a concise, national-level briefing on CPT code 88350, its clinical role, and the payer landscape affecting its reimbursement and utilization.